If Indonesia’s HIV- and TB-program targets are to be reached by 2020, the design of both programs needs improvement, the Office of the Inspector General said, emphasizing shortcomings in the HIV program in particular. This was the second OIG audit of Indonesia’s Global Fund grants since the Global Fund’s investments in the country began, in 2003.
You are here
Office of the Inspector General
OIG audit of Global Fund grants to South Sudan highlights that risk mitigation "needs significant improvement"
The Global Fund’s Office of the Inspector General (OIG), in its second audit of Global Fund grants to South Sudan, found that the country has made progress across the three diseases despite facing long-standing political instability, economic dependence on oil, and inadequate capacity of human resources for health.
Global Fund grants to Malawi need improved financial controls and interventions for adolescent girls and young women, OIG says
A second audit by the Office of the Inspector General of Global Fund grants in Malawi has highlighted weaknesses in financial controls within two of the country’s three Principal Recipients (Ministry of Health and ActionAid International Malawi), and in the country’s interventions for adolescent girls and young women (AGYW), among other issues.
OIG advisory review identifies opportunities to strengthen Global Fund efforts to remove human rights-related barriers to access
An advisory review by the Office of the Inspector General (OIG) has identified steps the Global Fund can take to strengthen its efforts to remove human rights-related barriers to accessing services for HIV, tuberculosis and malaria, even as it acknowledges that the Fund is "one of the leading organizations to include the removal of human rights-related barriers to services among its strategic objectives." The recommendations fall under three b
OIG investigation of phishing fraud in Senegal finds “multiple control lapses” within Ministry of Health and Social Action
In an investigation of Global Fund grants to Senegal, the Office of the Inspector General (OIG) found that Global Fund monies destined for the purchase of tuberculosis diagnostic equipment, for Senegal’s Tuberculosis/Resilient and Sustainable Systems for Health grant, were unwittingly transferred to fraudsters posing as the Principal Recipient’s (PR) supplier.
The Global Fund’s 42nd Board Meeting confirms 2020-2022 Allocations, committee selection processes, and expansion of wambo.org
On 14-15 November 2019, the Global Fund Board held its 42nd meeting in Geneva, Switzerland. A ‘pre-day’ of information, discussion and interactive sessions was held on 13 November. Aidspan and the GFO/OFM were present, with observer status. The main decisions made at the meeting, in chronological order, are described below.
First OIG audit of Liberia’s Global Fund grants highlights that financial management arrangements need ‘significant improvement’
The Global Fund has made some progress in establishing ethics- and integrity-related structures and processes, OIG says
In the first audit by the Office of the Inspector General of ethics and integrity (risks, structures, and processes) at the Global Fund, the OIG assessed the adequacy and effectiveness of the Ethics and Integrity Framework across Global Fund structures and processes, within the Secretariat, governance bodies, and its operations, including those beyond the Secretariat, such as relationships with implementers and suppliers.
The Office of the Inspector General (OIG) of the Global Fund, in its second audit of grants in Nepal, found that the country has made significant progress in the fight against HIV, tuberculosis and malaria.
OIG’s follow-up audit of Global Fund grants to Democratic Republic of Congo highlights need to improve stock management and data quality
A new Office of the Inspector General (OIG) audit of Global Fund grants in the Democratic Republic of Congo acknowledges successes across the three diseases achieved under extraordinarily challenging circumstances, but also highlights stockouts or insufficient stocks of health commodities, data inaccuracies relating to people living with HIV,